Impact of evidence-based medicine on the treatment of patients with unresectable hepatocellular carcinoma
✍ Scribed by E. G. GIANNINI; G. BODINI; M. CORBO; V. SAVARINO; D. RISSO; M. A. DI NOLFO; P. DEL POGGIO; L. BENVEGNÙ; F. FARINATI; M. ZOLI; F. BORZIO; E. CATURELLI; M. CHIARAMONTE; F. TREVISANI; FOR THE ITALIAN LIVER CANCER (ITA.LI.CA.) GROUP
- Book ID
- 108605821
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 232 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0269-2813
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## BACKGROUND. Transcatheter arterial chemoembolization (TACE) has been used as a palliative treatment for patients with unresectable hepatocellular carcinoma (HCC), but its prognostic usefulness has not previously been clarified. ## METHODS. The authors reviewed all patients treated at their ins
## Abstract ## BACKGROUND The therapeutic results of nonsurgical treatment for patients with hepatocellular carcinoma (HCC) have been poor, and improved treatments are needed. The authors recently developed a new technique called __angiographic subsegmentectomy__ for the treatment of patients with